Jean Zhao

USPTO Granted Patents = 11 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 2 (Patent Applications = 14)

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 15(Granted Patents)

Location History:

Boston, MA (US) (2021)
Brookline, MA (US) (2012 - 2022)

Company Filing History:

11 out of 1,207

Dana-farber-cancer Institute Inc.

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12478665 - Cancer vaccine compositions and methods for using same to prevent and/or treat cancer (2025-11-25),

2. 11366100 - P13K-MTORC1-S6K1 signaling pathway biomarkers predictive of anti-cancer responses (2022-06-21),

3. 11318139 - Methods for treating brain metastases using combinations of anti-P13K and anti-mTOR agents (2022-05-03),

4. 11155857 - Methods for measuring RNA translation rates (2021-10-26),

5. 11155556 - Pyrimido-diazepinone kinase scaffold compounds and methods for treating PI3K-mediated disorders (2021-10-26),

6. 10960008 - Methods for treating PTEN deficient epithelial cancers using a combination of anti-PI3KBETA and anti-immune checkpoint agents (2021-03-30),

7. 10875844 - Salicylate inhibitors of MELK and methods of use (2020-12-29),

8. 10544138 - Tricyclic kinase inhibitors of MELK and methods of use (2020-01-28),

9. 10254283 - Biomarker for MELK activity and methods of using same (2019-04-09),

10. 9540619 - MELK regulation for the treatment of breast cancer (2017-01-10),

11. 8178317 - Compositions and methods for identifying transforming and tumor suppressor genes (2012-05-15),

Title: The Innovative Contributions of Jean Zhao

Introduction

Jean Zhao is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of cancer research, holding a total of 11 patents. Her work focuses on identifying biomarkers and developing treatment methods for cancer therapies.

Latest Patents

One of her latest patents is titled "P13K-MTORC1-S6K1 signaling pathway biomarkers predictive of anti-cancer responses." This invention is based on the identification of novel biomarkers that predict responsiveness to anti-cancer therapies. Another notable patent is "Methods for treating brain metastases using combinations of anti-P13K and anti-mTOR agents." This invention relates to methods of treating brain metastases using synergistic combinations of anti-PI3K and anti-mTOR therapies, demonstrating the therapeutic benefits of blocking these pathways.

Career Highlights

Jean Zhao has worked with esteemed organizations such as Dana-Farber Cancer Institute Inc. and Harvard College. Her research has significantly advanced the understanding of cancer treatment and has the potential to improve patient outcomes.

Collaborations

Throughout her career, Jean has collaborated with notable colleagues, including Yubao Wang and Nathanael Schiander Gray. These collaborations have further enriched her research and contributed to her innovative work in cancer therapies.

Conclusion

Jean Zhao's contributions to cancer research through her patents and collaborations highlight her role as a leading inventor in the field. Her innovative approaches continue to pave the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.